Although statistical significance was not reached, PRAME IHC–negative patients showed a trend toward worse treatment outcomes in GCB-DLBCL ( Supplemental Figure 4 ).
← all excerpts
Tumor-associated antigen PRAME exhibits dualistic functions that are targetable in diffuse large B cell lymphoma.
1
—
—